Literature DB >> 16154199

Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells.

Valeria Gasperi1, Filomena Fezza, Paola Spagnuolo, Nicoletta Pasquariello, Mauro Maccarrone.   

Abstract

We have recently reported that leptin (L) and progesterone (P) stimulate the activity and the expression of the endocannabinoid-degrading enzyme anandamide hydrolase (fatty acid amide hydrolase, FAAH) in human lymphoma U937 cells, but not in human neuroblastoma CHP100 cells. We have also shown that leptin and progesterone do not affect the proteins of the endocannabinoid system that synthesize and transport AEA. Here, we have summarized these findings, and have extended them by investigating the effect of leptin and progesterone on the endogenous levels of AEA. We show that leptin and progesterone significantly reduce AEA content in U937 cells (down to approximately 20% and approximately 50% of the controls, respectively), whereas they are ineffective on AEA levels in CHP100 cells. In addition, we show that leptin and progesterone prevent the pro-apoptotic activity of AEA in U937 cells, reducing DNA fragmentation by approximately 50% and approximately 35% compared to controls, respectively. Instead, neither hormone affects apoptosis induced by AEA in CHP100 cells. Since the anti-apoptotic activity of leptin and progesterone parallels their effect on FAAH, it can be suggested that enhanced degradation of AEA is the means to protect U937 cells against the toxicity of this compound. Altogether, these data suggest that a cell-specific regulation of FAAH gene might modulate the apoptotic potential of endocannabinoids along the neuroimmune axis. These findings might be relevant for the development of cell-selective drugs targeted towards FAAH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154199     DOI: 10.1016/j.neuro.2005.08.002

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle.

Authors:  Anthony H Taylor; Muna S Abbas; Marwan A Habiba; Justin C Konje
Journal:  Histochem Cell Biol       Date:  2010-04-06       Impact factor: 4.304

3.  Decreased circulating anandamide levels in preeclampsia.

Authors:  Attila Molvarec; Gergely Fügedi; Eszter Szabó; Balázs Stenczer; Szilvia Walentin; János Rigó
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

4.  Gene expression of the endocannabinoid system in endometrium through menstrual cycle.

Authors:  Keisuke Tanaka; Akwasi A Amoako; Sally Mortlock; Peter A W Rogers; Sarah J Holdsworth-Carson; Jacqueline F Donoghue; Wan Tinn Teh; Grant W Montgomery; Brett McKinnon
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

5.  Peripheral endocannabinoid system activity in patients treated with sibutramine.

Authors:  Stefan Engeli; Karsten Heusser; Jürgen Janke; Kerstin Gorzelniak; Sándor Bátkai; Pál Pacher; Judith Harvey-White; Friedrich C Luft; Jens Jordan
Journal:  Obesity (Silver Spring)       Date:  2008-03-06       Impact factor: 5.002

6.  New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.

Authors:  Thangesweran Ayakannu; Anthony H Taylor; Timothy H Marczylo; Justin C Konje
Journal:  Med Sci Monit Basic Res       Date:  2019-03-07

7.  Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma.

Authors:  Thangesweran Ayakannu; Anthony H Taylor; Monica Bari; Nicoletta Mastrangelo; Mauro Maccarrone; Justin C Konje
Journal:  Front Oncol       Date:  2019-12-19       Impact factor: 6.244

Review 8.  The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.

Authors:  Maria-Paz Viveros; Francisco-Javier Bermúdez-Silva; Ana-Belén Lopez-Rodriguez; Edward J Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.